Assignee profile:

GEISTLICH PHARMA AG

City:

Wolhusen

Country:

Switzerland

Published Applications:

41

Last publication date:

2026-01-29

Patent Grants:

33

Last grant date:

2026-01-27

Top Inventors for applications by GEISTLICH PHARMA AG

These are the the leading inventors for applications assigned to GEISTLICH PHARMA AG:

Recent patent applications by GEISTLICH PHARMA AG

GEISTLICH PHARMA AG based in Wolhusen, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-01-29
US20260027126A1
Human necessities

COMBINATION THERAPY FOR TREATING CANCERS

#2 | 2026-01-22
US20260021106A1
Human necessities

COMBINATION THERAPY FOR TREATING CANCERS

#3 | 2024-11-07 βœ… Patent 12,534,443 granted on 2026-01-27
US20240368097A1
Chemistry; metallurgy

PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS

#4 | 2024-06-20
US20240199563A1
Chemistry; metallurgy

ANTIMICROBIAL AND ANTICANCER AGENTS

#5 | 2023-12-07
US20230389911A1
Human necessities

APPLICATOR OF A SPONGEOUS COLLAGEN MEMBRANE AND KIT COMPRISING SUCH APPLICATOR AND MEMBRANE

#6 | 2023-05-25 βœ… Patent 11,999,709 granted on 2024-06-04
US20230159477A1
Chemistry; metallurgy

Processes for preparing oxathiazin-like compounds

#7 | 2022-10-13
US20220323452A1
Human necessities

METHODS AND COMPOSITIONS FOR INHIBITING GAPDH

#8 | 2022-10-13 βœ… Patent 12,514,847 granted on 2026-01-06
US20220323423A1
Human necessities

OXATHIAZIN_DIOXIDE FOR TREATING, PREVENTING, INHIBITING OR REDUCING CYTOKINE RELEASE

#9 | 2022-10-06
US20220313702A1
Human necessities

OXATHIAZIN COMPOUNDS FOR INHIBITING GAPDH

#10 | 2022-01-27 βœ… Patent 11,571,494 granted on 2023-02-07
US20220023498A1
Human necessities

Method for treating subjects suffering from chronic ulcers

#11 | 2021-06-03 βœ… Patent 11,591,302 granted on 2023-02-28
US20210163432A1
Chemistry; metallurgy

Processes for preparing oxathiazin-like compounds

#12 | 2020-12-17 βœ… Patent 11,357,891 granted on 2022-06-14
US20200390939A1
Human necessities

Collagen matrix or granulate blend of bone substitute material

#13 | 2020-12-17 βœ… Patent 10,960,107 granted on 2021-03-30
US20200390934A1
Human necessities

Collagen matrix or granulate blend of bone substitute material

#14 | 2020-12-17 βœ… Patent 10,918,592 granted on 2021-02-16
US20200390690A1
Human necessities

Injectable aqueous implant formulation containing ascorbic acid

#15 | 2020-11-05 βœ… Patent 11,633,519 granted on 2023-04-25
US20200345893A1
Human necessities

Dried implant composition and injectable aqueous implant formulation

#16 | 2020-10-15 βœ… Patent 10,869,949 granted on 2020-12-22
US20200324020A1
Human necessities

Method for treating subjects suffering from chronic ulcers

#17 | 2020-01-16 βœ… Patent 10,646,615 granted on 2020-05-12
US20200016293A1
Human necessities

Bone substitute material

#18 | 2019-12-26 βœ… Patent 10,968,190 granted on 2021-04-06
US20190389819A1
Chemistry; metallurgy

Processes for preparing oxathiazin-like compounds

#19 | 2019-07-11 βœ… Patent 10,646,619 granted on 2020-05-12
US20190209737A1
Human necessities

Bone substitute material

#20 | 2019-07-11 βœ… Patent 10,695,461 granted on 2020-06-30
US20190209735A1
Human necessities

Dried implant composition and injectable aqueous implant formulation

#21 | 2019-06-20 βœ… Patent 11,351,287 granted on 2022-06-07
US20190184059A1
Human necessities

Bone substitute material

#22 | 2019-03-28 βœ… Patent 10,736,902 granted on 2020-08-11
US20190091233A1
Human necessities

Method of treating triple negative breast cancer

#23 | 2019-03-21 βœ… Patent 10,544,114 granted on 2020-01-28
US20190084950A1
Chemistry; metallurgy

Process for preparing oxathiazin-like compounds

#24 | 2018-12-27 βœ… Patent 10,392,355 granted on 2019-08-27
US20180370932A1
Chemistry; metallurgy

Processes for preparing oxathiazin-like compounds

#25 | 2018-12-06 βœ… Patent 10,835,640 granted on 2020-11-17
US20180344902A1
Human necessities

Resorbable crosslinked form stable membrane for use outside the oral cavity

#26 | 2018-09-13 βœ… Patent 10,300,171 granted on 2019-05-28
US20180256785A1
Human necessities

Resorbable crosslinked form stable membrane

#27 | 2017-07-13 βœ… Patent 9,844,555 granted on 2017-12-19
US20170196876A1
Human necessities

Oxathiazine derivatives as antibacterial and anticancer agents

#28 | 2016-06-16 βœ… Patent 9,655,997 granted on 2017-05-23
US20160166737A1
Human necessities

Collagen sponge

#29 | 2016-06-09 βœ… Patent 9,624,187 granted on 2017-04-18
US20160159759A1
Chemistry; metallurgy

Oxathiazine derivatives as antibacterial and anticancer agents

#30 | 2016-05-26 βœ… Patent 10,029,028 granted on 2018-07-24
US20160144071A1
Human necessities

Biomimetic collagen-hydroxyapatite composite material

#31 | 2015-07-02
US20150182556A1
Human necessities

HYDROPHILIC PHOSPHATE GROUP CONTAINING DEHYDRATED PARTIALLY PURIFIED BONE REPLACEMENT MATERIAL

#32 | 2015-07-02 βœ… Patent 9,241,943 granted on 2016-01-26
US20150182534A1
Human necessities

Oxathiazine derivatives as antibacterial and anticancer agents

#33 | 2013-12-26 βœ… Patent 9,066,995 granted on 2015-06-30
US20130345825A1
Human necessities

Bone substitute material

#34 | 2013-07-25 βœ… Patent 8,852,617 granted on 2014-10-07
US20130189199A1
Human necessities

Antimicrobial dental care preparation

#35 | 2013-04-11 βœ… Patent 9,028,866 granted on 2015-05-12
US20130089606A1
Human necessities

Methods and compositions for oral pharmaceutical therapy

#36 | 2013-01-10 βœ… Patent 8,852,580 granted on 2014-10-07
US20130011463A1
Human necessities

Method and device for synovial cell-charged collagen membrane or gel

#37 | 2012-05-24 βœ… Patent 8,734,524 granted on 2014-05-27
US20120130506A1
Human necessities

Bone substitute material

#38 | 2012-04-05 βœ… Patent 8,491,592 granted on 2013-07-23
US20120083790A1
Human necessities

Device for the application of bone substitute material

#39 | 2011-11-10 βœ… Patent 8,992,946 granted on 2015-03-31
US20110274756A1
Human necessities

Method and membrane for tissue regeneration

#40 | 2011-11-03 βœ… Patent 9,770,538 granted on 2017-09-26
US20110270394A1
Human necessities

Method and membrane for skin regeneration

#41 | 2009-06-25
US20090163479A1
Human necessities

USE OF TAUROLIDINE TO TREAT TUMORS

Also check out GEISTLICH PHARMA AG's (Wolhusen, Switzerland) applicant profile with 28 patent applications submitted.

AssigneeID:

3371 ⎘